Javascript must be enabled to continue!
Solid Pseudopapillary Neoplasm of the Pancreas - A rare entity with emphasis on the differential diagnosis.
View through CrossRef
Solid Pseudopapillary Neoplasm of Pancreas (SPNP) is a rare, low-grade malignant solid-cysticneoplasm with papillary architecture. It accounts for 2% to 3% of pancreatic neoplasms and 0.9% to2.7% of exocrine pancreatic neoplasms. It occurs almost exclusively in young women and has anexcellent postsurgical curative rate. Metastasis is rare although it may be locally aggressive. Thesolid pseudopapillary neoplasm of the pancreas pose a diagnostic challenge both clinically andradiologically as it has a nonspecific clinical presentation with vague radiologic features.Histopathological evaluation and immunohistochemistry remains the gold standard in reaching adefinitive diagnosis. Due to its low incidence, the clinical and pathologic features of SPNP have notbeen extensively studied. We report a case of a 32-year-old lady with solid pseudopapillaryneoplasm of the pancreas that was suspected on abdominal CECT as a well-defined mass in theampullary-periampullary region abutting head of the pancreas and confirmed on histopathologicalevaluation with immunohistochemistry.
Siddharth Health Research and Social Welfare Society
Title: Solid Pseudopapillary Neoplasm of the Pancreas - A rare entity with emphasis on the differential diagnosis.
Description:
Solid Pseudopapillary Neoplasm of Pancreas (SPNP) is a rare, low-grade malignant solid-cysticneoplasm with papillary architecture.
It accounts for 2% to 3% of pancreatic neoplasms and 0.
9% to2.
7% of exocrine pancreatic neoplasms.
It occurs almost exclusively in young women and has anexcellent postsurgical curative rate.
Metastasis is rare although it may be locally aggressive.
Thesolid pseudopapillary neoplasm of the pancreas pose a diagnostic challenge both clinically andradiologically as it has a nonspecific clinical presentation with vague radiologic features.
Histopathological evaluation and immunohistochemistry remains the gold standard in reaching adefinitive diagnosis.
Due to its low incidence, the clinical and pathologic features of SPNP have notbeen extensively studied.
We report a case of a 32-year-old lady with solid pseudopapillaryneoplasm of the pancreas that was suspected on abdominal CECT as a well-defined mass in theampullary-periampullary region abutting head of the pancreas and confirmed on histopathologicalevaluation with immunohistochemistry.
Related Results
Malignant gastrointestinal PEComa misdiagnosed as Solid pseudopapillary neoplasm of ovary: a case report
Malignant gastrointestinal PEComa misdiagnosed as Solid pseudopapillary neoplasm of ovary: a case report
Abstract
Background: Perivascular epithelial cell malignant tumor (PEComa) is a mesenchymal tumor with the characteristics of perivascular epithelioid cells in histology an...
Solid Pseudopapillary Neoplasm of Pancreas, Presentation and Management of a Rare Case
Solid Pseudopapillary Neoplasm of Pancreas, Presentation and Management of a Rare Case
Solid Pseudopapillary Neoplasm (SPN) of the pancreas is a rare neoplasm that typically affects young females. It is a low-grade malignant tumor which is quite commonly misdiagnosed...
A Phase 1b, Dose-Finding Study Of Ruxolitinib Plus Panobinostat In Patients With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF): Identification Of The Recommended Phase 2 Dose
A Phase 1b, Dose-Finding Study Of Ruxolitinib Plus Panobinostat In Patients With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF): Identification Of The Recommended Phase 2 Dose
Abstract
Background
Myelofibrosis (MF) is a myeloproliferative neoplasm associated with progressive, debilitating symptoms that ...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...
Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms
Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms
Abstract
Background
Preoperative ultrasound (US) evaluation of central and lateral neck compartments is recommended for all pati...
Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine‐needle aspiration?
Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine‐needle aspiration?
AbstractThyroid fine‐needle aspiration (FNA) is a standard procedure for the clinical triage of thyroid nodules. The diagnosis of an adequately sampled thyroid FNA is generally gro...
Pediatric solid pseudopapillary neoplasm of the pancreas
Pediatric solid pseudopapillary neoplasm of the pancreas
AbstractBackgroundSolid pseudopapillary neoplasm of the pancreas (SPN) in children is rare tumor with low malignant potential. Some tumors however behave aggressively. There is ver...
Pancreatic cystic tumors: an update
Pancreatic cystic tumors: an update
Abstract
Pancreatic cystic tumors (PCTs) comprise a heterogeneous group of entities, accounting for 2% to 10% of pancreatic lesions. The most common types are intraduct...

